Exclusive

Publication

Byline

यूपी में भारी बारिश-जलभराव, नुकसान पर योगी के आदेश- प्रभावितों को 24 घंटे में मिले मुआवजा

लखनऊ, अगस्त 16 -- यूपी के कई जिलों में भारी बारिश हो रही है। साथ ही मौसम विभाग ने आज के लिए भी कई जिलों में भारी बारिश की चेतावनी दी है। मौसम विभाग के अनुसार प्रदेश के पूर्वी, पश्चिम संभागों में चेताव... Read More


UFC 330 Results: Islam Makhachev Beats Ian Machado Garry; Mackenzie Dern Retains Title | Full List of Winners

India, Aug. 16 -- UFC 330 saw a memorable night of action in Philadelphia, with Islam Makhachev and Mackenzie Dern defending their titles in two championship bouts. Makhachev extended his remarkable U... Read More


आरपीएफ बैंड की धुनों से गूंजा प्रयागराज जंक्शन

प्रयागराज, अगस्त 16 -- प्रयागराज, वरिष्ठ संवाददाता। स्वतंत्रता दिवस पर प्रयागराज जंक्शन देशभक्ति की धुनों से गूंज उठा। उत्तर मध्य रेलवे के रेल सुरक्षा बल (आरपीएफ) बैंड ने स्टेशन परिसर में शानदार प्रस्... Read More


Sailors 'tried to jump off' US warship: What Homer knew and science now explains about being at sea for long

India, Aug. 16 -- More than 5,000 American sailors and Marines aboard the aircraft carrier USS Abraham Lincoln have spent over 250 consecutive days at sea, the longest stretch without a port call by a... Read More


Singapore Clinical Trial: An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembrolizumab Versus Chemotherapy in Subjects with Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma that Expresses HER2 (IHC 1+ and Greater)

Singapore, Aug. 16 -- The Health Sciences Authority received information related to the study titled 'An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembr... Read More


Singapore Clinical Trial: A Randomized, Open-label, Phase 3 Study of Rina-S ± Bevacizumab Versus Investigator's Choice of Platinum-Based Chemotherapy ± Bevacizumab as 2L Treatment in Participants With Recurrent Platinum-Sensitive Ovarian Cancer

Singapore, Aug. 16 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-label, Phase 3 Study of Rina-S ± Bevacizumab Versus Investigator's Choice of Pl... Read More


Singapore Clinical Trial: ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Compared to Durvalumab in Participants with Unresectable Stage III NSCLC Without Progression After Platinum-based Concurrent Chemoradiation Therapy.

Singapore, Aug. 16 -- The Health Sciences Authority received information related to the study titled 'ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Com... Read More


Singapore Clinical Trial: A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared with Pembrolizumab monotherapy in participants with advanced colorectal adenocarcinoma (CRC) harboring microsatellite instability (MSI) and/or deficient mismatch repair (DMMR)

Singapore, Aug. 16 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared w... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemotherapy (modified FOLFIRINOX or Gemcitabine plus Nab-paclitaxel) with or without Zoldonrasib (RMC 9805) as First-line Treatment in Patients with Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma (RASolute 305)

Singapore, Aug. 16 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemothera... Read More


Singapore Clinical Trial: A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose Study to Evaluate the Gastric Emptying Delay, Pharmacokinetics, Safety, and Tolerability of Eloralintide in Participants with Obesity or Overweight

Singapore, Aug. 16 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose St... Read More